Published in Health Policy on January 01, 2003
Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ (2005) 3.05
Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J (2010) 2.93
Costs and cost-effectiveness of malaria control interventions--a systematic review. Malar J (2011) 2.53
Rethinking the economic costs of malaria at the household level: evidence from applying a new analytical framework in rural Kenya. Malar J (2006) 1.78
Malaria eradication: the economic, financial and institutional challenge. Malar J (2008) 1.62
Mosquito larval source management for controlling malaria. Cochrane Database Syst Rev (2013) 1.58
Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania. Am J Trop Med Hyg (2010) 1.46
Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J (2005) 1.39
Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso. PLoS One (2010) 1.32
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali. Cost Eff Resour Alloc (2009) 1.23
Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme. Malar J (2011) 1.15
The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya. Malar J (2013) 1.15
Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet (2007) 1.13
The effect of a single blood meal on the phenotypic expression of insecticide resistance in the major malaria vector Anopheles funestus. Malar J (2008) 1.11
Is malaria illness among young children a cause or a consequence of low socioeconomic status? evidence from the united Republic of Tanzania. Malar J (2012) 1.09
The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets. BMC Public Health (2006) 1.06
Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Malar J (2013) 1.05
Costs of illness due to endemic cholera. Epidemiol Infect (2011) 1.04
Malaria vector control practices in an irrigated rice agro-ecosystem in central Kenya and implications for malaria control. Malar J (2008) 1.03
The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity? Malar J (2010) 1.02
Artemisinin resistance--modelling the potential human and economic costs. Malar J (2014) 1.01
Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective. BMC Infect Dis (2013) 0.99
Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania. PLoS One (2013) 0.98
Constraints to universal coverage: inequities in health service use and expenditures for different health conditions and providers. Int J Equity Health (2011) 0.96
The evil circle of poverty: a qualitative study of malaria and disability. Malar J (2012) 0.95
The Burden of Early Exposure to Malaria in the United States, 1850-1860: Malnutrition and Immune Disorders. J Econ Hist (2007) 0.90
Trends in malaria morbidity among health care-seeking children under age five in Mopti and Sévaré, Mali between 1998 and 2006. Malar J (2010) 0.88
Genome wide linkage study, using a 250K SNP map, of Plasmodium falciparum infection and mild malaria attack in a Senegalese population. PLoS One (2010) 0.88
Are there geographic and socio-economic differences in incidence, burden and prevention of malaria? A study in southeast Nigeria. Int J Equity Health (2009) 0.87
"My children and I will no longer suffer from malaria": a qualitative study of the acceptance and rejection of indoor residual spraying to prevent malaria in Tanzania. Malar J (2012) 0.86
Social implications of malaria and their relationships with poverty. Mediterr J Hematol Infect Dis (2012) 0.85
The economic burden of malaria on households and the health system in Enugu State southeast Nigeria. PLoS One (2013) 0.84
Malaria and protective behaviours: is there a malaria trap? Malar J (2013) 0.82
Health impact and cost-effectiveness of a private sector bed net distribution: experimental evidence from Zambia. Malar J (2013) 0.82
Psychological distress in Ghana: associations with employment and lost productivity. Int J Ment Health Syst (2013) 0.81
Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production. Front Plant Sci (2016) 0.78
Investigating payment coping mechanisms used for the treatment of uncomplicated malaria to different socio-economic groups in Nigeria. Afr Health Sci (2015) 0.77
The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey. Malar J (2005) 0.77
Quality of life and the risk of contracting malaria by multivariate analysis in the Brazilian Amazon region. Malar J (2014) 0.75
Spatial mapping and prediction of Plasmodium falciparum infection risk among school-aged children in Côte d'Ivoire. Parasit Vectors (2016) 0.75
Cost of illness for outpatients attending public and private hospitals in Bangladesh. Int J Equity Health (2016) 0.75
Economic burden of malaria inpatients during National Malaria Elimination Programme: estimation of hospitalization cost and its inter-province variation. Malar J (2017) 0.75
Detecting mutations in PfCRT and PfMDR1 genes among Plasmodium falciparum isolates from Saudi Arabia by pyrosequencing. Parasitol Res (2011) 0.75
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg (2004) 8.13
Maternal health in poor countries: the broader context and a call for action. Lancet (2006) 4.72
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg (2007) 4.51
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Health financing to promote access in low income settings-how much do we know? Lancet (2004) 4.31
The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission. Lancet (2010) 4.24
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Improving the health of the global poor. Science (2002) 3.69
Mobilising financial resources for maternal health. Lancet (2006) 3.53
The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg (2007) 3.44
Assessing capacity for health policy and systems research in low and middle income countries* Health Res Policy Syst (2003) 3.29
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J (2008) 3.25
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health (2004) 3.22
Health-financing reforms in southeast Asia: challenges in achieving universal coverage. Lancet (2011) 3.14
Financing of health systems to achieve the health Millennium Development Goals in low-income countries. Lancet (2010) 3.10
Can working with the private for-profit sector improve utilization of quality health services by the poor? A systematic review of the literature. Int J Equity Health (2007) 2.89
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg (2009) 2.84
Countdown to 2015: assessment of donor assistance to maternal, newborn, and child health between 2003 and 2006. Lancet (2008) 2.83
Is private health care the answer to the health problems of the world's poor? PLoS Med (2008) 2.82
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan (2007) 2.35
Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08. Lancet (2010) 2.33
What can global health institutions do to help strengthen health systems in low income countries? Health Res Policy Syst (2010) 2.31
Scaling-up and sustaining insecticide-treated net coverage. Lancet Infect Dis (2003) 2.27
Cost-effectiveness of social marketing of insecticide-treated nets for malaria control in the United Republic of Tanzania. Bull World Health Organ (2003) 2.26
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg (2004) 2.23
Dual job holding by public sector health professionals in highly resource-constrained settings: problem or solution? Bull World Health Organ (2005) 2.22
Countdown to 2015: tracking donor assistance to maternal, newborn, and child health. Lancet (2006) 2.08
Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial. PLoS Med (2009) 2.05
The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med (2011) 1.99
From Mexico to Mali: progress in health policy and systems research. Lancet (2008) 1.99
Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics (2009) 1.97
Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010. Lancet (2013) 1.95
Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res (2009) 1.95
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health (2006) 1.91
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J (2008) 1.90
Scaling up priority health interventions in Tanzania: the human resources challenge. Health Policy Plan (2007) 1.86
Countdown to 2015: changes in official development assistance to maternal, newborn, and child health in 2009-10, and assessment of progress since 2003. Lancet (2012) 1.86
Health policy and systems research: defining the terrain; identifying the methods. Health Policy Plan (2011) 1.72
Intervention complexity--a conceptual framework to inform priority-setting in health. Bull World Health Organ (2005) 1.72
Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth (2014) 1.70
Learning from Thailand's health reforms. BMJ (2004) 1.61
Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature. Int J Qual Health Care (2010) 1.59
Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res (2012) 1.59
Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity. Health Res Policy Syst (2013) 1.58
Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Malar J (2008) 1.55
Information for decision making from imperfect national data: tracking major changes in health care use in Kenya using geostatistics. BMC Med (2007) 1.52
The household costs of health care in rural South Africa with free public primary care and hospital exemptions for the poor. Trop Med Int Health (2009) 1.49
The Affordable Medicines Facility--malaria: killing it slowly. Lancet (2012) 1.47
Classical versus relational approaches to understanding controls on a contract with independent GPs in South Africa. Health Econ (2003) 1.45
Cost-effectiveness of malaria control interventions when malaria mortality is low: insecticide-treated nets versus in-house residual spraying in India. Soc Sci Med (2004) 1.37
Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar J (2010) 1.35
The role of regulation in influencing income-generating activities among public sector doctors in Peru. Hum Resour Health (2007) 1.30
A review of health resource tracking in developing countries. Health Policy Plan (2007) 1.30
Donor funding for newborn survival: an analysis of donor-reported data, 2002-2010. PLoS Med (2012) 1.27
The economics of malaria in pregnancy--a review of the evidence and research priorities. Lancet Infect Dis (2007) 1.27
Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Health Econ (2009) 1.25
Taskforce on Innovative International Financing for Health Systems: showing the way forward. Bull World Health Organ (2010) 1.23
Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics (2009) 1.23
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Malar J (2008) 1.13
The economics of social marketing: the case of mosquito nets in Tanzania. Soc Sci Med (2005) 1.11
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study. Malar J (2012) 1.10
A new face for private providers in developing countries: what implications for public health? Bull World Health Organ (2003) 1.05
Coping with the cost burdens of illness: combining qualitative and quantitative methods in longitudinal, household research. Scand J Public Health Suppl (2007) 1.03
Financing reforms of public health services in China: lessons for other nations. Soc Sci Med (2002) 1.01
Public satisfaction as a measure of health system performance: a study of nine countries in the former Soviet Union. Health Policy (2013) 0.99
Patient costs for paediatric hospital admissions in Tanzania: a neglected burden? Health Policy Plan (2010) 0.99
The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study. Appl Health Econ Health Policy (2003) 0.98
The effect of performance-related pay of hospital doctors on hospital behaviour: a case study from Shandong, China. Hum Resour Health (2005) 0.98
Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya. PLoS One (2013) 0.95
Social solidarity and willingness to tolerate risk- and income-related cross-subsidies within health insurance: experiences from Ghana, Tanzania and South Africa. Health Policy Plan (2012) 0.94
Research to support universal coverage reforms in Africa: the SHIELD project. Health Policy Plan (2012) 0.93
Willingness to pay and determinants of choice for improved malaria treatment in rural Nepal. Soc Sci Med (2003) 0.92
The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries. Vaccine (2014) 0.90
Cost-effectiveness of long-lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam. PLoS One (2013) 0.88
Price discrimination in obstetric services--a case study in Bangladesh. Health Econ (2004) 0.86
Estimating the demand for health services in four poor districts of Cape Town, South Africa. Int Health (2011) 0.86
Health sector regulation in Thailand: recent progress and the future agenda. Health Policy (2003) 0.85
Changing mindsets in health policy and systems research. Lancet (2012) 0.83
Contracts in the real world: case studies from Southern Africa. Soc Sci Med (2005) 0.79
The consequences of hospital autonomization in Colombia: a transaction cost economics analysis. Health Policy Plan (2012) 0.79
The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial. Malar J (2013) 0.78
p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer. J Low Genit Tract Dis (2015) 0.78
Don't let misinformation derail the trachoma elimination programme. BMJ (2012) 0.75
The fallacy of competing interest statements: no shortcut to rigour in research. J R Soc Med (2009) 0.75
Reed Elsevier and the arms trade revisited. Lancet (2007) 0.75
Management initiatives in a community-based health insurance scheme. Int J Health Plann Manage (2007) 0.75
Health systems development in four Caribbean territories: introduction. Health Policy (2002) 0.75